These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34319951)

  • 1. 68Ga-DOTATATE PET/CT in Primary Pulmonary Lymphoepithelioma-Like Carcinoma.
    Shang Q; Pang Y; Meng T; Hao B; Chen H
    Clin Nucl Med; 2022 Feb; 47(2):187-189. PubMed ID: 34319951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Case of Brown Tumor on 68Ga-DOTATATE PET/CT and 18F-FDG PET/CT.
    Yao X; Ou X
    Clin Nucl Med; 2022 Jan; 47(1):88-89. PubMed ID: 34874352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18F-FDG PET/CT and 68Ga-DOTATATE PET/CT Findings in a Patient With Primary Renal Well-Differentiated Neuroendocrine Tumor.
    Şahin R; Baykal Koca S; Yücetaş U; Çermik TF; Ergül N
    Clin Nucl Med; 2022 Jul; 47(7):e503-e505. PubMed ID: 35384913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 68Ga-DOTATATE PET/CT imaging of indeterminate pulmonary nodules and lung cancer.
    Walker R; Deppen S; Smith G; Shi C; Lehman J; Clanton J; Moore B; Burns R; Grogan EL; Massion PP
    PLoS One; 2017; 12(2):e0171301. PubMed ID: 28182730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in pulmonary neuroendocrine tumors.
    Kayani I; Conry BG; Groves AM; Win T; Dickson J; Caplin M; Bomanji JB
    J Nucl Med; 2009 Dec; 50(12):1927-32. PubMed ID: 19910422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Combined Interpretation of 68Ga-DOTATATE PET/CT and 18F-FDG PET/CT in Metastatic Gastroenteropancreatic Neuroendocrine Tumors: A Classification System With Prognostic Impact.
    Hayes AR; Furtado O'Mahony L; Quigley AM; Gnanasegaran G; Caplin ME; Navalkissoor S; Toumpanakis C
    Clin Nucl Med; 2022 Jan; 47(1):26-35. PubMed ID: 34874347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated PET/MRI With 68Ga-DOTATATE and 18F-FDG in Pheochromocytomas and Paragangliomas: An Initial Study.
    Xu S; Pan Y; Zhou J; Ju H; Zhang Y
    Clin Nucl Med; 2022 Apr; 47(4):299-304. PubMed ID: 35143455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatin receptor imaging with [
    Zhao L; Pang Y; Wang Y; Chen J; Zhuang Y; Zhang J; Zhao L; Sun L; Wu H; Chen X; Lin Q; Chen H
    Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1360-1373. PubMed ID: 34665275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratumoral Heterogeneity in a Patient With Metastatic Thymic Carcinoma on 18F-FDG, 68Ga-DOTATATE, and 68Ga-FAPI04 PET/CT.
    Isik EG; Kuyumcu S; Ozkan ZG; Has Simsek D; Sanli Y
    Clin Nucl Med; 2022 Jan; 47(1):e79-e80. PubMed ID: 34392280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solitary Contralateral Adrenal Metastasis of Renal Cell Carcinoma: 68Ga-DOTATATE PET/CT Findings.
    Filizoglu N; Ozguven S
    Clin Nucl Med; 2022 Jan; 47(1):e41-e42. PubMed ID: 34132679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the application of 18F-FDG and 68Ga-DOTATATE PET/CT in neuroendocrine tumors: A retrospective study.
    Hu X; Li D; Wang R; Wang P; Cai J
    Medicine (Baltimore); 2023 May; 102(19):e33726. PubMed ID: 37171344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discordance Between Histopathologic Grading and Dual-Tracer PET/CT Findings in Metastatic NETs and Outcome of
    Adnan A; Basu S
    J Nucl Med Technol; 2022 Sep; 50(3):248-255. PubMed ID: 34876476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MIB-1 Index-Stratified Assessment of Dual-Tracer PET/CT with
    Sampathirao N; Basu S
    J Nucl Med Technol; 2017 Mar; 45(1):34-41. PubMed ID: 28154019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of (18F)FDG PET/CT and (68Ga)DOTATATE PET/CT imaging methods in terms of detection of histological subtype and related SUVmax values in patients with pulmonary carcinoid tumors.
    Komek H; Can C; Urakçi Z; Kepenek F
    Nucl Med Commun; 2019 May; 40(5):517-524. PubMed ID: 30694875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation and Comparison of Somatostatin Receptor Type 2 Immunohistochemical Scoring Systems with 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography Imaging in Gastroenteropancreatic Neuroendocrine Neoplasms.
    Yu J; Cao F; Zhao X; Xie Q; Lu M; Li J; Yang Z; Sun Y
    Neuroendocrinology; 2022; 112(4):358-369. PubMed ID: 34077939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 68Ga-DOTATATE PET/CT imaging for insulinoma in MEN1 patient with endogenous hyperinsulinemic hypoglycemia: A case report.
    Liu Y; Zhao X; Zhang J; Wang J; Zhang Z; Dai M; Wang N; Jing F; Wang T; Tian W
    Medicine (Baltimore); 2022 Aug; 101(34):e30252. PubMed ID: 36042606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic Poorly Differentiated Thyroid Cancer With Heterogeneous Distribution of 18F-FDG, 68Ga-DOTATATE, and 68Ga-PSMA on PET/CT.
    Civan C; Isik EG; Simsek DH
    Clin Nucl Med; 2021 Apr; 46(4):e212-e213. PubMed ID: 33156050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conversion from FDG-negative to -positive during follow-up in a rare case of pulmonary lymphoepithelioma-like carcinoma.
    Shen DH; Cheng CY; Lin LF; Gao HW; Cheng YL; Chen CY
    Clin Nucl Med; 2012 Jul; 37(7):679-81. PubMed ID: 22691512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging Characteristics of Coexisting Primary Pulmonary Carcinoid Tumor and Multiple Myeloma on 18F-FDG and 68Ga-DOTATATE PET/CT.
    Lu Y
    Clin Nucl Med; 2019 Nov; 44(11):914-915. PubMed ID: 31306189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 68Ga-DOTATATE and 18F-FDG PET/CT for the Management of Esthesioneuroblastoma of the Sphenoclival Region.
    Dadgar H; Norouzbeigi N; Ahmadzadehfar H; Assadi M
    Clin Nucl Med; 2020 Aug; 45(8):e363-e364. PubMed ID: 32558717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.